36 related articles for article (PubMed ID: 31860561)
1. Pitfalls of NMDA Receptor Modulation by Neuroactive Steroids. The Effect of Positive and Negative Modulation of NMDA Receptors in an Animal Model of Schizophrenia.
Holubova K; Chvojkova M; Hrcka Krausova B; Vyklicky V; Kudova E; Chodounska H; Vyklicky L; Vales K
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356650
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic-like activity of cannabidiolic acid methyl ester in the MK-801 mouse model of schizophrenia: Role for cannabinoid CB1 and serotonin-1A receptors.
Richardson B; Clarke C; Blundell J; Bambico FR
Eur J Neurosci; 2024 May; 59(9):2403-2415. PubMed ID: 38385841
[TBL] [Abstract][Full Text] [Related]
3. The GluN2C/D-specific positive allosteric modulator CIQ rescues delay-induced working memory deficits in mice.
Dembeck M; Dieterich DC; Fendt M
Behav Brain Res; 2024 Jan; 456():114716. PubMed ID: 37839756
[TBL] [Abstract][Full Text] [Related]
4. Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity.
Andrade YCP; Ropke J; Viana TG; Fanelli C; Minaldi E; Batista LA; Issy AC; Del Bel EA; Rodrigues LCM; Liégeois JF; Moreira FA
Behav Pharmacol; 2021 Feb; 32(1):2-8. PubMed ID: 33399294
[TBL] [Abstract][Full Text] [Related]
5. Effect of D-pinitol on MK-801-induced schizophrenia-like behaviors in mice.
Kim JY; Kong CH; Kim DY; Min JW; Park K; Jeon M; Kang WC; Jung SY; Ryu JH
Phytother Res; 2023 Dec; 37(12):5904-5915. PubMed ID: 37654104
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of Aripiprazole on Electroencephalography-Recorded Gamma-Band Auditory Steady-State Response, Spontaneous Gamma Oscillations and Behavior in a Schizophrenia Rat Model.
Adraoui FW; Hettak K; Viardot G; Alix M; Guiffard S; Meot B; L'Hostis P; Maurin A; Delpy E; Drieu La Rochelle C; Carvalho K
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256109
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and transcriptional effects of repeated electroconvulsive seizures in the neonatal MK-801-treated rat model of schizophrenia.
Lee J; Huh S; Park K; Kang N; Yu HS; Park HG; Kim YS; Kang UG; Won S; Kim SH
Psychopharmacology (Berl); 2024 Apr; 241(4):817-832. PubMed ID: 38081977
[TBL] [Abstract][Full Text] [Related]
8.
Santillán-Urquiza MA; Herrera-Ruiz M; Zamilpa A; Jiménez-Ferrer E; Román-Ramos R; Alegría-Herrera EY; Tortoriello J
Evid Based Complement Alternat Med; 2019; 2019():8404258. PubMed ID: 31428176
[TBL] [Abstract][Full Text] [Related]
9. Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.
Hansen KB; Wollmuth LP; Bowie D; Furukawa H; Menniti FS; Sobolevsky AI; Swanson GT; Swanger SA; Greger IH; Nakagawa T; McBain CJ; Jayaraman V; Low CM; Dell'Acqua ML; Diamond JS; Camp CR; Perszyk RE; Yuan H; Traynelis SF
Pharmacol Rev; 2021 Oct; 73(4):298-487. PubMed ID: 34753794
[TBL] [Abstract][Full Text] [Related]
10. Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments.
Martínez AL; Brea J; Rico S; de Los Frailes MT; Loza MI
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576069
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of GluN2C-containing NMDA receptors in the external globus pallidus increases firing of fast spiking neurons and improves motor function in a hemiparkinsonian mouse model.
Liu J; Shelkar GP; Sarode LP; Gawande DY; Zhao F; Clausen RP; Ugale RR; Dravid SM
Neurobiol Dis; 2021 Mar; 150():105254. PubMed ID: 33421565
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Dihydropyrrolo[1,2-
Epplin MP; Mohan A; Harris LD; Zhu Z; Strong KL; Bacsa J; Le P; Menaldino DS; Traynelis SF; Liotta DC
J Med Chem; 2020 Jul; 63(14):7569-7600. PubMed ID: 32538088
[TBL] [Abstract][Full Text] [Related]
13. GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.
Suryavanshi PS; Ugale RR; Yilmazer-Hanke D; Stairs DJ; Dravid SM
Br J Pharmacol; 2014 Feb; 171(3):799-809. PubMed ID: 24236947
[TBL] [Abstract][Full Text] [Related]
14. Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats.
Wang X; Luo C; Mao XY; Li X; Yin JY; Zhang W; Zhou HH; Liu ZQ
Brain Res; 2019 Sep; 1719():30-39. PubMed ID: 31121159
[TBL] [Abstract][Full Text] [Related]
15. Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus).
Hoffman KL; Basurto E
Behav Brain Res; 2014 Sep; 271():203-11. PubMed ID: 24933188
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update.
Cadinu D; Grayson B; Podda G; Harte MK; Doostdar N; Neill JC
Neuropharmacology; 2018 Nov; 142():41-62. PubMed ID: 29196183
[TBL] [Abstract][Full Text] [Related]
17. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
Neill JC; Barnes S; Cook S; Grayson B; Idris NF; McLean SL; Snigdha S; Rajagopal L; Harte MK
Pharmacol Ther; 2010 Dec; 128(3):419-32. PubMed ID: 20705091
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic-like profile of CIQ isomers in animal models of schizophrenia.
Gawai P; Upadhyay R; Gakare SG; Sarode L; Dravid SM; Ugale RR
Behav Pharmacol; 2020 Sep; 31(6):524-534. PubMed ID: 31860561
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
